tradingkey.logo


Nutex Health Inc

NUTX
168.100USD
+0.760+0.45%
āļ›āļīāļ” 12/24, 13:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
1.16BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
7.72P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Nutex Health Inc āļšāļĢāļīāļĐāļąāļ—

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

āļ‚āđ‰āļ­āļĄāļđāļĨ Nutex Health Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™NUTX
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Nutex Health Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 18, 2011
āļ‹āļĩāļ­āļĩāđ‚āļ­Vo (Thomas T)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™800
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Mar 18
āļ—āļĩāđˆāļ­āļĒāļđāđˆ6030 S. Rice Ave.
āđ€āļĄāļ·āļ­āļ‡HOUSTON
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX - NASDAQ BASIC
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ77081
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ17136600557
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.nutexhealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™NUTX
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 18, 2011
āļ‹āļĩāļ­āļĩāđ‚āļ­Vo (Thomas T)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Nutex Health Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Dr. Thomas T. Vo, M.D.
Dr. Thomas T. Vo, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
43.91K
--
Dr. Kelvin Spears
Dr. Kelvin Spears
Director
Director
32.03K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
President, Director
President, Director
4.50K
+0.02%
Ms. Pamela W. Montgomery, Esq.
Ms. Pamela W. Montgomery, Esq.
Chief Legal Officer - Healthcare, Corporate Secretary
Chief Legal Officer - Healthcare, Corporate Secretary
--
--
Ms. Cheryl Grenas
Ms. Cheryl Grenas
Independent Director
Independent Director
--
--
Mr. Jon C. Bates, CPA
Mr. Jon C. Bates, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Smith Rodriguez
Ms. Jennifer Smith Rodriguez
Investor Relations
Investor Relations
--
--
Mr. Mitchell R. Creem
Mr. Mitchell R. Creem
Independent Director
Independent Director
--
--
Mr. Michael L. Reed
Mr. Michael L. Reed
Lead Independent Director
Lead Independent Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Dr. Thomas T. Vo, M.D.
Dr. Thomas T. Vo, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
43.91K
--
Dr. Kelvin Spears
Dr. Kelvin Spears
Director
Director
32.03K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
President, Director
President, Director
4.50K
+0.02%
Ms. Pamela W. Montgomery, Esq.
Ms. Pamela W. Montgomery, Esq.
Chief Legal Officer - Healthcare, Corporate Secretary
Chief Legal Officer - Healthcare, Corporate Secretary
--
--
Ms. Cheryl Grenas
Ms. Cheryl Grenas
Independent Director
Independent Director
--
--
Mr. Jon C. Bates, CPA
Mr. Jon C. Bates, CPA
Chief Financial Officer
Chief Financial Officer
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 4 āļĄāļĩ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 4 āļĄāļĩ.āļ„.
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Net patient service revenue
59.82M
88.69%
Capitation revenue, net
6.70M
9.93%
Management fees
585.90K
0.87%
SaaS revenue
344.97K
0.51%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Net patient service revenue
59.82M
88.69%
Capitation revenue, net
6.70M
9.93%
Management fees
585.90K
0.87%
SaaS revenue
344.97K
0.51%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 15 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 15 āļž.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Micro Hospital Holding LLC
25.65%
Topline Capital Management, LLC
7.87%
Pertento Partners LLP
4.06%
BlackRock Institutional Trust Company, N.A.
3.36%
The Vanguard Group, Inc.
3.03%
āļ­āļ·āđˆāļ™ āđ†
56.04%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Micro Hospital Holding LLC
25.65%
Topline Capital Management, LLC
7.87%
Pertento Partners LLP
4.06%
BlackRock Institutional Trust Company, N.A.
3.36%
The Vanguard Group, Inc.
3.03%
āļ­āļ·āđˆāļ™ āđ†
56.04%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Corporation
25.65%
Hedge Fund
13.52%
Investment Advisor
13.14%
Investment Advisor/Hedge Fund
4.44%
Research Firm
2.71%
Individual Investor
2.49%
Bank and Trust
0.60%
Pension Fund
0.40%
Venture Capital
0.04%
āļ­āļ·āđˆāļ™ āđ†
37.01%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q3
208
2.10M
37.75%
+607.28K
2025Q2
177
3.43M
61.79%
+32.77K
2025Q1
184
3.16M
60.95%
-250.59K
2024Q4
192
3.04M
55.87%
+53.51K
2024Q3
188
2.60M
48.20%
-162.49K
2024Q2
188
2.40M
44.53%
-366.24K
2024Q1
190
2.62M
196.03%
+226.54K
2023Q4
189
2.33M
52.04%
-38.68K
2023Q3
186
2.36M
52.85%
+54.70K
2023Q2
179
2.38M
54.41%
+29.44K
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Micro Hospital Holding LLC
1.81M
32.65%
+31.81K
+1.79%
Apr 23, 2025
Topline Capital Management, LLC
309.13K
5.56%
+129.42K
+72.01%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
225.56K
4.06%
+191.55K
+563.22%
Jun 30, 2025
The Vanguard Group, Inc.
189.93K
3.42%
+55.12K
+40.88%
Jun 30, 2025
Morgan Stanley & Co. LLC
30.61K
0.55%
+29.15K
+1985.49%
Jun 30, 2025
American Century Investment Management, Inc.
104.06K
1.87%
+29.70K
+39.95%
Jun 30, 2025
Millennium Management LLC
32.09K
0.58%
-28.61K
-47.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
78.86K
1.42%
+42.48K
+116.79%
Jun 30, 2025
Chang (Michael L)
80.06K
1.44%
--
--
Apr 23, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 2 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 2 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
State Street SPDR S&P Health Care Services ETF
1.02%
First Trust Dow Jones Select MicroCap Index Fund
0.68%
VictoryShares Small Cap Free Cash Flow ETF
0.61%
Texas Capital Texas Small Cap Equity Index ETF
0.51%
Janus Henderson Small Cap Growth Alpha ETF
0.39%
ALPS Barron's 400 ETF
0.32%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.3%
Vanguard US Momentum Factor ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Texas Capital Texas Equity Index ETF
0.12%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.02%
First Trust Dow Jones Select MicroCap Index Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.68%
VictoryShares Small Cap Free Cash Flow ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.61%
Texas Capital Texas Small Cap Equity Index ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.51%
Janus Henderson Small Cap Growth Alpha ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.39%
ALPS Barron's 400 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.32%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.3%
Vanguard US Momentum Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.18%
Principal U.S. Small-Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.15%
Texas Capital Texas Equity Index ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.12%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Apr 05, 2024
Merger
15→1
Apr 05, 2024
Merger
15→1
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Jun 19, 2024
Merger
10→1
Apr 05, 2024
Merger
15→1
Apr 05, 2024
Merger
15→1
Apr 05, 2024
Merger
15→1
Apr 05, 2024
Merger
15→1

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āđƒāļ„āļĢāļ„āļ·āļ­āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Nutex Health Inc?


āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Nutex Health Inc āđ„āļ”āđ‰āđāļāđˆ:
Micro Hospital Holding LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 1.81M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 32.65% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Topline Capital Management, LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 309.13K āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 5.56% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
BlackRock Institutional Trust Company, N.A. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 225.56K āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.06% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
The Vanguard Group, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 189.93K āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 3.42% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Morgan Stanley & Co. LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 30.61K āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 0.55% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”

āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Nutex Health Inc āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Nutex Health Inc āđ„āļ”āđ‰āđāļāđˆ
Micro Hospital Holding LLC
Topline Capital Management, LLC
Pertento Partners LLP

āļĄāļĩāļāļĩāđˆāļŠāļ–āļēāļšāļąāļ™āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Nutex Health Inc (NUTX)?


āļ“ āļ§āļąāļ™āļ—āļĩāđˆ 2025Q3 āļĄāļĩāļŠāļ–āļēāļšāļąāļ™āļˆāļģāļ™āļ§āļ™ 208 āđāļŦāđˆāļ‡āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Nutex Health Inc āđ‚āļ”āļĒāļĄāļĩāļĄāļđāļĨāļ„āđˆāļēāļĢāļ§āļĄāļ›āļĢāļ°āļĄāļēāļ“ 2.10M āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 37.75% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” āđ€āļĄāļ·āđˆāļ­āđ€āļ—āļĩāļĒāļšāļāļąāļšāļ§āļąāļ™āļ—āļĩāđˆ 2025Q2 āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™āđ„āļ”āđ‰āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™ -24.04%

āđāļŦāļĨāđˆāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŦāļĨāļąāļāļ‚āļ­āļ‡ Nutex Health Inc āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āđ€āļĄāļ·āđˆāļ­āļ§āļąāļ™āļ—āļĩāđˆ FY2024Q1 āļ˜āļļāļĢāļāļīāļˆāļ”āđ‰āļēāļ™ Net patient service revenue āļŠāļĢāđ‰āļēāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāđ‰āļāļąāļš Nutex Health Inc āļ„āļīāļ”āđ€āļ›āđ‡āļ™āļĄāļđāļĨāļ„āđˆāļē 59.82M āđāļĨāļ°āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 88.69% āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļĢāļ§āļĄ
KeyAI
î™